Your browser doesn't support javascript.
loading
Clinical characteristics and treatment outcomes of HER2 mutation and HER2 fusion in 22 patients with advanced breast cancer.
Mu, Yuxin; Meng, Yanchun; Du, Yiqun; Liu, Xiaojun; Zhang, Jian.
Afiliação
  • Mu Y; Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Meng Y; Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Du Y; Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Liu X; Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhang J; Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center, Shanghai, China.
Thorac Cancer ; 14(34): 3381-3388, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37863840
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article